Zobrazeno 1 - 10
of 313
pro vyhledávání: '"Esperanza B, Papadopoulos"'
Autor:
Florent Malard, Myriam Labopin, Christina Cho, Didier Blaise, Esperanza B. Papadopoulos, Jakob Passweg, Richard O’Reilly, Edouard Forcade, Molly Maloy, Liisa Volin, Hugo Castro-Malaspina, Yosr Hicheri, Ann A. Jakubowski, Corentin Orvain, Sergio Giralt, Mohamad Mohty, Arnon Nagler, Miguel-Angel Perales
Publikováno v:
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-11 (2018)
Abstract Background Graft-versus-host disease (GVHD) is one of the leading causes of non-relapse mortality and morbidity after allogeneic hematopoietic stem cell transplantation (allo-HCT). Methods We evaluated the outcomes of two well-established st
Externí odkaz:
https://doaj.org/article/db7a0aa4e22246feb663ac34dbbbbb58
Autor:
Maximilian Stahl, Andriy Derkach, Noushin Farnoud, Jan Philipp Bewersdorf, Troy Robinson, Christopher Famulare, Christina Cho, Sean Devlin, Kamal Menghrajani, Minal A. Patel, Sheng F. Cai, Linde A. Miles, Robert L. Bowman, Mark B. Geyer, Andrew Dunbar, Zachary D. Epstein‐Peterson, Erin McGovern, Jessica Schulman, Jacob L. Glass, Justin Taylor, Aaron D. Viny, Eytan M. Stein, Bartlomiej Getta, Maria E. Arcila, Qi Gao, Juliet Barker, Brian C. Shaffer, Esperanza B. Papadopoulos, Boglarka Gyurkocza, Miguel‐Angel Perales, Omar Abdel‐Wahab, Ross L. Levine, Sergio A. Giralt, Yanming Zhang, Wenbin Xiao, Nidhi Pai, Elli Papaemmanuil, Martin S. Tallman, Mikhail Roshal, Aaron D. Goldberg
Publikováno v:
American Journal of Hematology. 98:79-89
Measurable residual disease (MRD) is a powerful prognostic factor in acute myeloid leukemia (AML). However, pre-treatment molecular predictors of immunophenotypic MRD clearance remain unclear. We analyzed a dataset of 211 patients with pre-treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4809b6a39e2e5c18436cf54a982f8f2b
https://doi.org/10.1002/ajh.26757
https://doi.org/10.1002/ajh.26757
Autor:
Andrew Lin, Samantha Brown, Molly Maloy, Josel D. Ruiz, Sean Devlin, Lauren DeRespiris, Anthony Proli, Ann A. Jakubowski, Esperanza B. Papadopoulos, Craig S. Sauter, Roni Tamari, Hugo Castro-Malaspina, Brian Shaffer, Juliet Barker, Miguel A. Perales, Sergio A. Giralt, Boglarka Gyurkocza
Publikováno v:
Leuk Lymphoma
Given prophylactic methotrexate (MTX) is often held in the setting of toxicity we investigated the impact of omitting minidose-MTX dose(s). Outcomes were compared between patients who had 1–3 doses omitted and those who received all four planned do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37bdb8b82d4ec0f9452c3eccb620e322
https://doi.org/10.1080/10428194.2022.2032036
https://doi.org/10.1080/10428194.2022.2032036
Autor:
John L. Vaughn, Samantha Brown, Esperanza B. Papadopoulos, Ann A. Jakubowski, Roni Tamari, Sergio A. Giralt, Doris M. Ponce, Christina Cho, Miguel-Angel Perales, Brian C. Shaffer, Boglarka Gyurkocza
Publikováno v:
Bone Marrow Transplantation. 57:1740-1742
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fba52845451bffbebfdf5fa92ea613d4
https://doi.org/10.1038/s41409-022-01783-7
https://doi.org/10.1038/s41409-022-01783-7
Autor:
Christina Cho, Molly A. Maloy, Sean M. Devlin, Omer Aras, Lawrence T. Dauer, Ann A. Jakubowski, Esperanza B. Papadopoulos, Miguel-Angel Perales, Theodore S. Rappaport, Sergio A. Giralt
Publikováno v:
Bone Marrow Transplant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a791ffb2d54ea4104a0d221556c19d74
https://doi.org/10.1038/s41409-022-01612-x
https://doi.org/10.1038/s41409-022-01612-x
Autor:
Roni Tamari, Michael Scordo, Jessica Flyn, Sean M. Devlin, Elizabeth Klein, Maria I. Cancio, Kevin J. Curran, Ann Jakubowski, Nancy A. Kernan, Esperanza B. Papadopoulos, Andromachi Scaradavou, Brian C. Shaffer, Gunjan Shah, Barbara Spitzer, Boglarka Gyurkocza, Sergio A Giralt, Miguel-Angel Perales, Jaap Jan Boelens
Publikováno v:
Transplantation and Cellular Therapy. 29:S169-S170
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1e202dd50568c349b4e85613fdcf90e
https://doi.org/10.1016/s2666-6367(23)00287-7
https://doi.org/10.1016/s2666-6367(23)00287-7
Autor:
Shlomo Elias, Samantha Brown, Sean M. Devlin, Juliet N. Barker, Christina Cho, David J. Chung, Parastoo B. Dahi, Sergio A Giralt, Boglarka Gyurkocza, Ann Jakubowski, Oscar B. Lahoud, Heather J Landau, Dr. Richard J. Lin, Esperanza B. Papadopoulos, Ioannis Politikos, Doris M. Ponce, Michael Scordo, Brian C. Shaffer, Gunjan L. Shah, Roni Tamari, James W. Young, Miguel-Angel Perales, Roni Shouval
Publikováno v:
Transplantation and Cellular Therapy. 29:S17-S18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f013048cd4a2c3c3ece4b5828849730
https://doi.org/10.1016/s2666-6367(23)00090-8
https://doi.org/10.1016/s2666-6367(23)00090-8
Geriatric Assessment and Outcomes of Allogeneic Hematopoietic Cell Transplantation in Older Patients
Autor:
Parastoo B. Dahi, Armin Shahrokni, Jessica Flynn, Sean M. Devlin, Ms. Stephanie Chinapen, Jennifer Ayala, Soni Brown, Sarah Bugen, Christina Cho, Boglarka Gyurkocza, Dr. Richard J. Lin, Esperanza B. Papadopoulos, Miguel-Angel Perales, Ioannis Politikos, Doris M. Ponce, Brian C. Shaffer, Gunjan L. Shah, Roni Tamari, James W. Young, Sergio A Giralt, Ann A. Jakubowski
Publikováno v:
Transplantation and Cellular Therapy. 29:S426-S427
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e795ed62669a9c5c7b922d113202f3ba
https://doi.org/10.1016/s2666-6367(23)00638-3
https://doi.org/10.1016/s2666-6367(23)00638-3
Autor:
Warren B Fingrut, Boglarka Gyurkocza, Jessica R. Flynn, Eric Davis, Sean M. Devlin, Andromachi Scaradavou, Stephanie Chinapen, Sean Quach, Christina Cho, Sergio A. Giralt, Ann A Jakubowski, Richard J. Lin, Esperanza B. Papadopoulos, Miguel-Angel Perales, Doris M Ponce, Brian Shaffer, Roni Tamari, James W Young, Ioannis Politikos, Juliet N. Barker
Publikováno v:
Blood advances.
While alternative donors extend transplant access, whether recipient ancestry impacts the time to allogeneic transplant is not established. We analyzed the likelihood of clinically significant delays to allograft by patient ancestry in 313 transplant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f43f6781d09196c63905e083a49c3676
https://pubmed.ncbi.nlm.nih.gov/36240477
https://pubmed.ncbi.nlm.nih.gov/36240477
Autor:
Anthony R. Mato, Doris M. Ponce, Esperanza B. Papadopoulos, Oscar B Lahoud, Lindsey E. Roeker, Andrew D. Zelenetz, Sean M. Devlin, Juliet N. Barker, Boglarka Gyurkocza, Parastoo B. Dahi, James W. Young, Guenther Koehne, Sergio Giralt, Molly Maloy, Craig S. Sauter, Ann A. Jakubowski, Miguel Perales, Hugo Castro-Malaspina
Publikováno v:
Blood Adv
Allogeneic hematopoietic stem cell transplantation (HSCT) may potentially cure patients with chronic lymphocytic leukemia (CLL) and Richter’s transformation (CLL-RT) or CLL without RT, but the impact of novel agents on HSCT is unclear. CLL-RT patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3f05cf87d1691b1409a9474ff4caec8
https://doi.org/10.1182/bloodadvances.2020003726
https://doi.org/10.1182/bloodadvances.2020003726